Genetic Mechanisms Highlight Shared Pathways for the Pathogenesis of Polygenic Type 1 Diabetes and Monogenic Autoimmune Diabetes

Overview

Journal Curr Diab Rep

Publisher Current Science

Specialty Endocrinology

Date 2019 Mar 20

PMID 30888520

Citations 14

Authors

Matthew B Johnson

Karen Cerosaletti

Sarah E Flanagan

Jane H Buckner

Affiliations

Soon will be listed here.

Abstract

Purpose Of Review: To highlight pathways important for the development of autoimmune diabetes by investigating shared mechanisms of disease in polygenic and monogenic diabetes.

Recent Findings: Genome-wide association studies have identified 57 genetic risk loci for type 1 diabetes. Progress has been made in unravelling the mechanistic effects of some of these variants, providing key insights into the pathogenesis of type 1 diabetes. Seven monogenic disorders have also been described where diabetes features as part of an autoimmune syndrome. Studying these genes in relation to polygenic risk loci provides a unique opportunity to dissect pathways important for the development of immune-mediated diabetes. Monogenic autoimmune diabetes can result from the dysregulation of multiple pathways suggesting that small effects on many immune processes are required to drive the autoimmune attack on pancreatic beta cells in polygenic type 1 diabetes. A breakdown in central and peripheral immune tolerance is a common theme in the genetic mechanisms of both monogenic and polygenic disease which highlights the importance of these checkpoints in the development and treatment of islet autoimmunity.

Citing Articles

Antigen-specific immunotherapies for autoimmune disease.

Buckner J Nat Rev Rheumatol. 2024; 21(2):88-97.

PMID: 39681709 DOI: 10.1038/s41584-024-01201-w.

Case Report: A novel mutation in in a patient with type 1 diabetes mellitus and haploinsufficiency of A20.

Cao C, Fu X, Wang X Front Endocrinol (Lausanne). 2023; 14:1131437.

PMID: 37324276 PMC: 10266219. DOI: 10.3389/fendo.2023.1131437.

Polygenic autoimmune disease risk alleles impacting B cell tolerance act in concert across shared molecular networks in mouse and in humans.

Harley I, Allison K, Scofield R Front Immunol. 2022; 13:953439.

PMID: 36090990 PMC: 9450536. DOI: 10.3389/fimmu.2022.953439.

Clinical and experimental treatment of type 1 diabetes.

Long S, Buckner J Clin Exp Immunol. 2022; 210(2):105-113.

PMID: 35980300 PMC: 9750829. DOI: 10.1093/cei/uxac077.

Genetic basis of defects in immune tolerance underlying the development of autoimmunity.

Hocking A, Buckner J Front Immunol. 2022; 13:972121.

PMID: 35979360 PMC: 9376219. DOI: 10.3389/fimmu.2022.972121.

References

Chen J, Ganguly A, Mucsi A, Meng J, Yan J, Detampel P . Strong adhesion by regulatory T cells induces dendritic cell cytoskeletal polarization and contact-dependent lethargy. J Exp Med. 2017; 214(2):327-338. PMC: 5294852. DOI: 10.1084/jem.20160620. View

Walunas T, Lenschow D, Bakker C, Linsley P, Freeman G, Green J . CTLA-4 can function as a negative regulator of T cell activation. Immunity. 1994; 1(5):405-13. DOI: 10.1016/1074-7613(94)90071-x. View

Kaul A, Gordon C, Crow M, Touma Z, Urowitz M, van Vollenhoven R . Systemic lupus erythematosus. Nat Rev Dis Primers. 2016; 2:16039. DOI: 10.1038/nrdp.2016.39. View

Lopez-Herrera G, Tampella G, Pan-Hammarstrom Q, Herholz P, Trujillo-Vargas C, Phadwal K . Deleterious mutations in LRBA are associated with a syndrome of immune deficiency and autoimmunity. Am J Hum Genet. 2012; 90(6):986-1001. PMC: 3370280. DOI: 10.1016/j.ajhg.2012.04.015. View

Gorman J, Hundhausen C, Kinsman M, Arkatkar T, Allenspach E, Clough C . The -P1104A Autoimmune Protective Variant Limits Coordinate Signals Required to Generate Specialized T Cell Subsets. Front Immunol. 2019; 10:44. PMC: 6355696. DOI: 10.3389/fimmu.2019.00044. View

Zornitzki T, Malnick S, Lysyy L, Knobler H . Interferon therapy in hepatitis C leading to chronic type 1 diabetes. World J Gastroenterol. 2015; 21(1):233-9. PMC: 4284340. DOI: 10.3748/wjg.v21.i1.233. View

Zamani M, Spaepen M, Bex M, Bouillon R, Cassiman J . Primary role of the HLA class II DRB1*0301 allele in Graves disease. Am J Med Genet. 2001; 95(5):432-7. DOI: 10.1002/1096-8628(20001218)95:5<432::aid-ajmg5>3.0.co;2-7. View

Dendrou C, Plagnol V, Fung E, Yang J, Downes K, Cooper J . Cell-specific protein phenotypes for the autoimmune locus IL2RA using a genotype-selectable human bioresource. Nat Genet. 2009; 41(9):1011-5. PMC: 2749506. DOI: 10.1038/ng.434. View

Garg G, Tyler J, Yang J, Cutler A, Downes K, Pekalski M . Type 1 diabetes-associated IL2RA variation lowers IL-2 signaling and contributes to diminished CD4+CD25+ regulatory T cell function. J Immunol. 2012; 188(9):4644-53. PMC: 3378653. DOI: 10.4049/jimmunol.1100272. View

10.

Stahl E, Raychaudhuri S, Remmers E, Xie G, Eyre S, Thomson B . Genome-wide association study meta-analysis identifies seven new rheumatoid arthritis risk loci. Nat Genet. 2010; 42(6):508-14. PMC: 4243840. DOI: 10.1038/ng.582. View

11.

Lucassen A, Julier C, Beressi J, Boitard C, Froguel P, Lathrop M . Susceptibility to insulin dependent diabetes mellitus maps to a 4.1 kb segment of DNA spanning the insulin gene and associated VNTR. Nat Genet. 1993; 4(3):305-10. DOI: 10.1038/ng0793-305. View

12.

Mayans S, Lackovic K, Nyholm C, Lindgren P, Ruikka K, Eliasson M . CT60 genotype does not affect CTLA-4 isoform expression despite association to T1D and AITD in northern Sweden. BMC Med Genet. 2007; 8:3. PMC: 1802068. DOI: 10.1186/1471-2350-8-3. View

13.

De Bruyne M, Bogaert D, Venken K, Van den Bossche L, Bonroy C, Roels L . A novel LPS-responsive beige-like anchor protein (LRBA) mutation presents with normal cytotoxic T lymphocyte-associated protein 4 (CTLA-4) and overactive T17 immunity. J Allergy Clin Immunol. 2018; 142(6):1968-1971. DOI: 10.1016/j.jaci.2018.08.026. View

14.

Barrett J, Clayton D, Concannon P, Akolkar B, Cooper J, Erlich H . Genome-wide association study and meta-analysis find that over 40 loci affect risk of type 1 diabetes. Nat Genet. 2009; 41(6):703-7. PMC: 2889014. DOI: 10.1038/ng.381. View

15.

Andlauer T, Buck D, Antony G, Bayas A, Bechmann L, Berthele A . Novel multiple sclerosis susceptibility loci implicated in epigenetic regulation. Sci Adv. 2016; 2(6):e1501678. PMC: 4928990. DOI: 10.1126/sciadv.1501678. View

16.

Owerbach D, GABBAY K . Localization of a type I diabetes susceptibility locus to the variable tandem repeat region flanking the insulin gene. Diabetes. 1993; 42(12):1708-14. DOI: 10.2337/diab.42.12.1708. View

17.

Zorn E, Nelson E, Mohseni M, Porcheray F, Kim H, Litsa D . IL-2 regulates FOXP3 expression in human CD4+CD25+ regulatory T cells through a STAT-dependent mechanism and induces the expansion of these cells in vivo. Blood. 2006; 108(5):1571-9. PMC: 1895505. DOI: 10.1182/blood-2006-02-004747. View

18.

de Weerd N, Samarajiwa S, Hertzog P . Type I interferon receptors: biochemistry and biological functions. J Biol Chem. 2007; 282(28):20053-7. DOI: 10.1074/jbc.R700006200. View

19.

Hogquist K, Baldwin T, Jameson S . Central tolerance: learning self-control in the thymus. Nat Rev Immunol. 2005; 5(10):772-82. DOI: 10.1038/nri1707. View

20.

Habib T, Funk A, Rieck M, Brahmandam A, Dai X, Panigrahi A . Altered B cell homeostasis is associated with type I diabetes and carriers of the PTPN22 allelic variant. J Immunol. 2011; 188(1):487-96. PMC: 3670766. DOI: 10.4049/jimmunol.1102176. View